SCHEMBL6170838

SCHEMBL6170838

O=C(c1cccc(Cl)c1)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.81
KMT2A Q03164 3/20 0.81
NPC1 O15118 2/20 0.81
RAB9A P51151 2/20 0.81
CLK1 P49759 1/20 0.62
DYRK1A Q13627 1/20 0.62
F7 P08709 1/20 0.62
F3 P13726 1/20 0.62
FLT3 P36888 2/20 0.58
NHERF1 O14745 3/20 0.57
ALOX15 P16050 1/20 0.53
GUSB P08236 1/20 0.53
HRH4 Q9H3N8 2/20 0.51
HRH3 Q9Y5N1 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
TSHR P16473 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
PDGFRB P09619 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172296 0.89 MEN1 (0.72) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6173193 0.89 MEN1 (0.64) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6172428 0.88 MEN1 (0.62) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6168411 0.86 MEN1 (0.82) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6404723 0.83 NHERF1 (0.62) MEN1KMT2ANPC1RAB9AF7
SCHEMBL17927587 0.80 NPC1 (0.64) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL7066826 0.80 PDGFRB (0.70) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6401667 0.79 NHERF1 (0.58) MEN1KMT2ANPC1RAB9AF7
SCHEMBL6169709 0.77 MEN1 (0.57) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6170060 0.77 MEN1 (0.57) MEN1KMT2ANPC1RAB9ACLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed